Skip to Main Content

Author Details

Satish K Pillai
Vitalant Research Institute, USA University of California san francisco
2001
133
41
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36695358Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size.AIDS2023
37910505The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latency.Cell Rep2023
37503697The US Federal Retail Pharmacy Program: Optimizing COVID-19 Vaccine Delivery Through a Strategic Public-Private Partnership.Public Health Rep2023
37292622A Novel Viral Assembly Inhibitor Blocks SARS-CoV-2 Replication in Airway Epithelial Cells.Res Sq2023
37209695Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States.Emerg Infect Dis2023
37233903Elevated Galectin-9 across the human brain correlates with HIV neuropathology and detrimental cognitive states.J Neurovirol2023
37127426Human galectin-9 potently enhances SARS-CoV-2 replication and inflammation in airway epithelial cells.J Mol Cell Biol2023
35107021IL10 trains macrophage profibrotic function after lung injury.Am J Physiol Lung Cell Mol Physiol2022
35378763Human Galectin-9 Potently Enhances SARS-CoV-2 Replication and Inflammation in Airway Epithelial Cells.bioRxiv2022
35762590Exploring antiviral and anti-inflammatory effects of thiol drugs in COVID-19.Am J Physiol Lung Cell Mol Physiol2022
36325323Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection.Front Immunol2022
35271559COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 2021-January 2022.MMWR Morb Mortal Wkly Rep2022
33351785TCF-1 regulates HIV-specific CD8+ T cell expansion capacity.JCI Insight2021
33536176Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity <i>Ex Vivo and In Vivo</i>.J Virol2021
34383729Alternative Methods for Grouping Race and Ethnicity to Monitor COVID-19 Outcomes and Vaccination Coverage.MMWR Morb Mortal Wkly Rep2021
33976386Hyaluronic acid is a negative regulator of mucosal fibroblast-mediated enhancement of HIV infection.Mucosal Immunol2021
33330868Thiol drugs decrease SARS-CoV-2 lung injury <i>in vivo</i> and disrupt SARS-CoV-2 spike complex binding to ACE2 <i>in vitro</i>.bioRxiv2021
32423515Strategies for Optimizing the Supply of N95 Filtering Facepiece Respirators During the Coronavirus Disease 2019 (COVID-19) Pandemic.Disaster Med Public Health Prep2020
31722757Reported variability in healthcare facility policies regarding healthcare personnel working while experiencing influenza-like illnesses: An emerging infections network survey.Infect Control Hosp Epidemiol2020
31917781Population Movement Patterns Among the Democratic Republic of the Congo, Rwanda, and Uganda During an Outbreak of Ebola Virus Disease: Results from Community Engagement in Two Districts - Uganda, March 2019.MMWR Morb Mortal Wkly Rep2020
32004427First Case of 2019 Novel Coronavirus in the United States.N Engl J Med2020
32943630SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.Nat Commun2020
32877446Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States.PLoS One2020
32901981μ-Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies.FASEB J2020
32470316Investigation and Serologic Follow-Up of Contacts of an Early Confirmed Case-Patient with COVID-19, Washington, USA.Emerg Infect Dis2020
32434889Seminal Plasma-Derived Extracellular-Vesicle Fractions from HIV-Infected Men Exhibit Unique MicroRNA Signatures and Induce a Proinflammatory Response in Cells Isolated from the Female Reproductive Tract.J Virol2020
32541947FOXO1 promotes HIV latency by suppressing ER stress in T cells.Nat Microbiol2020
32196387Strategies to Inform Allocation of Stockpiled Ventilators to Healthcare Facilities During a Pandemic.Health Secur2020
32511477SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area.medRxiv2020
30645648Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency.PLoS Pathog2019
31009256Approach to Prioritizing Respiratory Protection When Demand Exceeds Supplies During an Influenza Pandemic: A Call to Action.Health Secur2019
30478799Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals.J Neurovirol2019
28766555The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon.Mucosal Immunol2018
29867942Granulocyte-Derived Extracellular Vesicles Activate Monocytes and Are Associated With Mortality in Intensive Care Unit Patients.Front Immunol2018
29714165Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4<sup>+</sup> T cells.Elife2018
29565842Initial Public Health Laboratory Response After Hurricane Maria - Puerto Rico, 2017.MMWR Morb Mortal Wkly Rep2018
29621203Notes from the Field: Pharmacy Needs After a Natural Disaster - Puerto Rico, September-October 2017.MMWR Morb Mortal Wkly Rep2018
28053103Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication <i>In Vitro</i> and Modulate HIV Restriction Factor Expression.J Virol2017
28329286Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection.Clin Infect Dis2017
28498985HIV Antibody Level as a Marker of HIV Persistence and Low-Level Viral Replication.J Infect Dis2017
29154748CDC Safety Training Course for Ebola Virus Disease Healthcare Workers.Emerg Infect Dis2017
29052340Absence of neurocognitive disadvantage associated with paediatric HIV subtype A infection in children on antiretroviral therapy.J Int AIDS Soc2017
29293934The Epidemiology of Foodborne Botulism Outbreaks: A Systematic Review.Clin Infect Dis2017
28511815Signature of the Sleeper Cell: A Biomarker of HIV Latency Revealed.Trends Immunol2017
28615711Identification and characterization of a rich population of CD34<sup>+</sup> mesenchymal stem/stromal cells in human parotid, sublingual and submandibular glands.Sci Rep2017
28520968Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies.J Infect Dis2017
28056005Zika Virus -10 Public Health Achievements in 2016 and Future Priorities.MMWR Morb Mortal Wkly Rep2017
26811980Ebola and Its Control in Liberia, 2014-2015.Emerg Infect Dis2016
27632552Implementation of a National Semen Testing and Counseling Program for Male Ebola Survivors - Liberia, 2015-2016.MMWR Morb Mortal Wkly Rep2016
27711033Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Persons with Possible Zika Virus Exposure - United States, September 2016.MMWR Morb Mortal Wkly Rep2016
  • 1 - 50 of 133

Recommended Authors

Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 3
University of Washington Medical Center
Career Start Year 2008
Number of shared co-authors 14
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 20
Clinical Center (CC)
Career Start Year 2006
Number of shared co-authors 10
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2006
Number of shared co-authors 8
Emory University School of Medicine
Career Start Year 2004
Number of shared co-authors 6
Goethe University Frankfurt, University Hospital
Career Start Year 2003
Number of shared co-authors 6
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 3
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 5
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 8
Harvard University
Career Start Year 1997
Number of shared co-authors 10
Ragon Institute of MGH
Career Start Year 1995
Number of shared co-authors 5
Geneva University Hospital
Career Start Year 1993
Number of shared co-authors 9
Hospital Germans Trias i Pujol
Career Start Year 1992
Number of shared co-authors 6
London School of Hygiene and Tropical Medicine
Career Start Year 1989
Number of shared co-authors 0
University Medical Center Utrecht
Career Start Year 1988
Number of shared co-authors 6
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year 1988
Number of shared co-authors 6
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 14
VA Medical Center
Career Start Year 1986
Number of shared co-authors 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 14
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 1
David Geffen School of Medicine, University of California los angeles
Career Start Year 1982
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 1980
Number of shared co-authors 12
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1979
Number of shared co-authors 17
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year 1979
Number of shared co-authors 9
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 6
Italian Ministry of Health
Career Start Year 1977
Number of shared co-authors 7
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Career Start Year 1976
Number of shared co-authors 1
Wistar Institute
Career Start Year 1958
Number of shared co-authors 9

Collaborators

University of California san francisco
Co-authored papers 19
Center for AIDS Research, University of California San Diego
Co-authored papers 16
Co-authored papers 13
University of California San Diego
Co-authored papers 9
Centers for Disease Control and Prevention
Co-authored papers 9
Co-authored papers 6
The Fenway Institute
Co-authored papers 6
Co-authored papers 6
University of California San Diego, USA VA San Diego Healthcare System
Co-authored papers 6
Lawrence Berkeley National Laboratory
Co-authored papers 5
University of California San Francisco
Co-authored papers 5
Institute for Translational HIV Research, University Hospital Essen
Co-authored papers 5
Co-authored papers 5
Vitalant Research Institute
Co-authored papers 5
Vitalant Research Institute
Co-authored papers 5
University of California, USA Gladstone Institutes san francisco
Co-authored papers 4
Co-authored papers 4
University of California
Co-authored papers 4
Gladstone Institute of Virology, USA University of California san francisco
Co-authored papers 4
University of California, university of california san diego
Co-authored papers 3
Vitalant Research Institute
Co-authored papers 3
Vitalant Research Institute
Co-authored papers 3
University of California san francisco
Co-authored papers 3
Centers for Disease Control and Prevention
Co-authored papers 3
Co-authored papers 3
Buck Institute for Research on Aging
Co-authored papers 3
Co-authored papers 3
Boston University
Co-authored papers 2
Co-authored papers 2
Centers for Disease Control and Prevention
Co-authored papers 2